Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Carisma Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −9 vs. Q3 2021
- Shares held
- 48.5M
- −1.56M (−3.1%) vs. Q3 2021
- Total value
- $39.1M
- −$5.07M (−11.5%) vs. Q3 2021
- New holders
- 18
- 26 more added
- Sold out
- 27
- 29 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CARM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 3 | $47.9K |
| Q4 2025 | 7 | $67.0K |
| Q3 2025 | 33 | $842.6K |
| Q2 2025 | 36 | $1.56M |
| Q1 2025 | 37 | $1.73M |
| Q4 2024 | 41 | $2.35M |
| Q3 2024 | 37 | $5.11M |
| Q2 2024 | 53 | $9.28M |
| Q1 2024 | 51 | $19.3M |
| Q4 2023 | 50 | $26.4M |
| Q3 2023 | 58 | $39.6M |
| Q2 2023 | 53 | $84.0M |
| Q1 2023 | 37 | $17.3M |
| Q4 2022 | 71 | $19.8M |
| Q3 2022 | 69 | $11.0M |
| Q2 2022 | 74 | $23.1M |
| Q1 2022 | 84 | $26.4M |
| Q4 2021 | 93 | $39.1M |
| Q3 2021 | 103 | $44.5M |
| Q2 2021 | 106 | $305.9M |
| Q1 2021 | 76 | $104.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Carisma Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −58,331−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −50,022−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −29,092−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −22,653−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −22,800−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −21,168−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −14,800−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −13,792−100.0% | Sold out |
| Quilter Plc | 0 | $0 | 0.00% | −13,933−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Savior LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −722−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −154−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −392−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −526−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |